SCHEMBL3710024

SCHEMBL3710024

CC(CCc1ccccc1)C(=O)Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.64
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ ALDH1A1 P00352 3/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ CNR2 P34972 1/20 0.46
▸ CYP2C9 P11712 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ HSP90AA1 P07900 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ KEAP1 Q14145 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11833507 0.86 LTB4R (0.54) TSHRSMN1; SMN2KMT2AHPGDALDH1A1
SCHEMBL11837264 0.86 LTB4R (0.54) TSHRSMN1; SMN2KMT2AHPGDALDH1A1
SCHEMBL12670558 0.84 TSHR (0.68) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL1073143 0.84 TSHR (0.68) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL473576 0.84 TSHR (0.68) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL264775 0.84 TSHR (0.68) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL9678140 0.84 TSHR (0.68) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL13971409 0.82 TSHR (0.66) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL16743937 0.82 TSHR (0.66) TSHRSMN1; SMN2KMT2AMEN1HTT
SCHEMBL6178883 0.82 TSHR (0.66) TSHRSMN1; SMN2KMT2AMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010088450-A2 METHODS FOR TREATING DISEASES ASSOCIATED WITH THE MODULATION OF SERCA CELLADON CORPORATION (US) 2010-08-05 — — WO disclosed
WO-2010088450-A2 METHODS FOR TREATING DISEASES ASSOCIATED WITH THE MODULATION OF SERCA CELLADON CORPORATION (US) 2010-08-05 — — WO disclosed
US-3992396-A TRANQUILIZERS, HYPNOTICS SANDOZ, INC. (US) 1976-11-16 — — US disclosed
Send feedback